{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T06:51:55Z","timestamp":1776408715144,"version":"3.51.2"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T00:00:00Z","timestamp":1775088000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T00:00:00Z","timestamp":1775088000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"DOI":"10.1007\/s00277-026-06964-8","type":"journal-article","created":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T05:27:30Z","timestamp":1775107650000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Letermovir improves the outcome of allogenic stem cell transplantation with anti-thymocyte globulin against acute leukemia and myelodysplastic syndromes"],"prefix":"10.1007","volume":"105","author":[{"given":"Shuto","family":"Negishi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kotaro","family":"Miyao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumiya","family":"Ohara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenta","family":"Motegi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroya","family":"Wakabayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitomi","family":"Sawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichiro","family":"Inagaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masashi","family":"Sawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,2]]},"reference":[{"issue":"16","key":"6964_CR1","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.1200\/JCO.2010.33.7212","volume":"29","author":"JR Wingard","year":"2011","unstructured":"Wingard JR et al (2011) Long-term survival and late deaths after allogeneic hematopoietic cell transplantation. J Clin Oncol 29(16):2230\u20139. https:\/\/doi.org\/10.1200\/JCO.2010.33.7212","journal-title":"J Clin Oncol"},{"issue":"17","key":"6964_CR2","doi-asserted-by":"publisher","first-page":"4651","DOI":"10.1182\/blood-2010-11-319509","volume":"117","author":"J Pidala","year":"2011","unstructured":"Pidala J et al (2011) Patient-reported quality of life is associated with severity of chronic graft-versus-host disease as measured by NIH criteria: report on baseline data from the Chronic GVHD Consortium. Blood 117(17):4651\u20137. https:\/\/doi.org\/10.1182\/blood-2010-11-319509","journal-title":"Blood"},{"issue":"5","key":"6964_CR3","doi-asserted-by":"publisher","first-page":"958","DOI":"10.3324\/haematol.2016.156356","volume":"102","author":"HJ Khoury","year":"2017","unstructured":"Khoury HJ et al (2017) Improved survival after acute graft-versus-host disease diagnosis in the modern era. Haematologica 102(5):958\u2013966. https:\/\/doi.org\/10.3324\/haematol.2016.156356","journal-title":"Haematologica"},{"issue":"10","key":"6964_CR4","doi-asserted-by":"publisher","first-page":"2942","DOI":"10.1182\/blood.v98.10.2942","volume":"98","author":"A Bacigalupo","year":"2001","unstructured":"Bacigalupo A et al (2001) Antithymocyte globulin for graft-versus-host disease prophylaxis in transplants from unrelated donors: 2 randomized studies from Gruppo Italiano Trapianti Midollo Osseo (GITMO). Blood 98(10):2942\u20137. https:\/\/doi.org\/10.1182\/blood.v98.10.2942","journal-title":"Blood"},{"issue":"19","key":"6964_CR5","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1056\/NEJMc1601364","volume":"374","author":"N Kr\u00f6ger","year":"2016","unstructured":"Kr\u00f6ger N, Solano C, Bonifazi F (2016) Antilymphocyte globulin for chronic graft-versus-host disease. N Engl J Med 374(19):1894\u20135. https:\/\/doi.org\/10.1056\/NEJMc1601364","journal-title":"N Engl J Med"},{"issue":"3","key":"6964_CR6","doi-asserted-by":"publisher","first-page":"153.e1","DOI":"10.1016\/j.jtct.2021.12.009","volume":"28","author":"K Miyao","year":"2022","unstructured":"Miyao K et al (2022) Antithymocyte globulin potentially could overcome an adverse effect of acute graft-versus-host disease in matched-related peripheral blood stem cell transplantation. Transplant Cell Ther 28(3):153.e1\u2013153.e11. https:\/\/doi.org\/10.1016\/j.jtct.2021.12.009","journal-title":"Transplant Cell Ther"},{"key":"6964_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtct.2023.01.026","author":"Y Takeuchi","year":"2023","unstructured":"Takeuchi Y et al (2023) Clinical benefit of low-dose antithymocyte globulin-thymoglobulin as graft-versus-host disease prophylaxis in patients receiving allogeneic peripheral blood stem cell transplantation from HLA-identical donors. Transplant Cell Ther. https:\/\/doi.org\/10.1016\/j.jtct.2023.01.026","journal-title":"Transplant Cell Ther"},{"issue":"8","key":"6964_CR8","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1080\/10428194.2016.1266624","volume":"58","author":"Y Arai","year":"2017","unstructured":"Arai Y, Jo T, Matsui H, Kondo T, Takaori-Kondo A (2017) Efficacy of antithymocyte globulin for allogeneic hematopoietic cell transplantation: a systematic review and meta-analysis. Leuk Lymphoma 58(8):1840\u20131848. https:\/\/doi.org\/10.1080\/10428194.2016.1266624","journal-title":"Leuk Lymphoma"},{"key":"6964_CR9","doi-asserted-by":"crossref","unstructured":"Boeckh M, Gooley TA, Myerson D, Cunningham T, Schoch G, Bowden RA Cytomegalovirus pp65 antigenemia-guided early treatment with ganciclovir versus ganciclovir at engraftment after allogeneic marrow transplantation: a randomized double-blind study, (in eng). Blood 88(10):4063\u20134071","DOI":"10.1182\/blood.V88.10.4063.bloodjournal88104063"},{"key":"6964_CR10","doi-asserted-by":"publisher","unstructured":"Goodrich JM et al (Dec 05 1991) Early treatment with ganciclovir to prevent cytomegalovirus disease after allogeneic bone marrow transplantation, (in eng). N Engl J Med 325(23):1601\u20131607. https:\/\/doi.org\/10.1056\/NEJM199112053252303","DOI":"10.1056\/NEJM199112053252303"},{"issue":"5","key":"6964_CR11","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1182\/blood.V93.5.1781","volume":"93","author":"M Boeckh","year":"1999","unstructured":"Boeckh M, Bowden RA, Gooley T, Myerson D, Corey L (1999) Successful modification of a pp65 antigenemia-based early treatment strategy for prevention of cytomegalovirus disease in allogeneic marrow transplant recipients, (in eng). Blood 93(5):1781\u20131782","journal-title":"Blood"},{"key":"6964_CR12","doi-asserted-by":"publisher","unstructured":"Chen K, Cheng MP, Hammond SP, Einsele H, Marty FM (2018) Antiviral prophylaxis for cytomegalovirus infection in allogeneic hematopoietic cell transplantation, (in eng)\u00a0Blood Adv.\u00a02(16):2159\u20132175. https:\/\/doi.org\/10.1182\/bloodadvances.2018016493","DOI":"10.1182\/bloodadvances.2018016493"},{"key":"6964_CR13","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.1056\/NEJMoa1706640","volume":"377","author":"FM Marty","year":"2017","unstructured":"Marty FM et al (2017) Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation, (in eng). N Engl J Med 377:2433\u20132444. https:\/\/doi.org\/10.1056\/NEJMoa1706640","journal-title":"N Engl J Med"},{"issue":"4","key":"6964_CR14","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1038\/s41409-020-01082-z","volume":"56","author":"Y Mori","year":"2021","unstructured":"Mori Y et al (2021) Efficacy of prophylactic letermovir for cytomegalovirus reactivation in hematopoietic cell transplantation: a multicenter real-world data, (in eng). Bone Marrow Transpl 56(4):853\u2013862. https:\/\/doi.org\/10.1038\/s41409-020-01082-z","journal-title":"Bone Marrow Transpl"},{"key":"6964_CR15","doi-asserted-by":"publisher","unstructured":"Yoshimura H et al (2022) Real-world efficacy of letermovir prophylaxis for cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation: A single-center retrospective analysis, (in eng). J Infect Chemother 28(9):1317\u20131323. https:\/\/doi.org\/10.1016\/j.jiac.2022.05.019","DOI":"10.1016\/j.jiac.2022.05.019"},{"key":"6964_CR16","doi-asserted-by":"publisher","unstructured":"Wolfe D et al (2021) Letermovir Prophylaxis and Cytomegalovirus Reactivation in Adult Hematopoietic Cell Transplant Recipients with and without Acute Graft Versus Host Disease, (in eng). Cancers (Basel) 13(21).\u00a0https:\/\/doi.org\/10.3390\/cancers13215572","DOI":"10.3390\/cancers13215572"},{"key":"6964_CR17","doi-asserted-by":"publisher","unstructured":"Derigs P et al (2021) Letermovir prophylaxis is effective in preventing cytomegalovirus reactivation after allogeneic hematopoietic cell transplantation: single-center real-world data, (in eng. Ann Hematol100(8):2087\u20132093.\u00a0https:\/\/doi.org\/10.1007\/s00277-020-04362-2","DOI":"10.1007\/s00277-020-04362-2"},{"key":"6964_CR18","doi-asserted-by":"publisher","unstructured":"Lin A et al (2021) Letermovir for Prevention of Cytomegalovirus Reactivation in Haploidentical and Mismatched Adult Donor Allogeneic Hematopoietic Cell Transplantation with Post-Transplantation Cyclophosphamide for Graft-versus-Host Disease Prophylaxis, (in eng). Transplant Cell Ther 27(1):85.e1-85.e6.\u00a0https:\/\/doi.org\/10.1016\/j.bbmt.2020.10.009","DOI":"10.1016\/j.bbmt.2020.10.009"},{"issue":"4","key":"6964_CR19","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1038\/s41409-019-0730-y","volume":"55","author":"P Sharma","year":"2020","unstructured":"Sharma P et al (2020) Letermovir prophylaxis through day 100 post transplant is safe and effective compared with alternative CMV prophylaxis strategies following adult cord blood and haploidentical cord blood transplantation. Bone Marrow Transplant 55(4):780\u2013786. https:\/\/doi.org\/10.1038\/s41409-019-0730-y","journal-title":"Bone Marrow Transplant"},{"issue":"23","key":"6964_CR20","doi-asserted-by":"publisher","first-page":"3664","DOI":"10.1182\/blood-2014-01-552984","volume":"123","author":"P Armand","year":"2014","unstructured":"Armand P et al (2014) Validation and refinement of the disease risk index for allogeneic stem cell transplantation. Blood 123(23):3664\u201371. https:\/\/doi.org\/10.1182\/blood-2014-01-552984","journal-title":"Blood"},{"issue":"8","key":"6964_CR21","doi-asserted-by":"publisher","first-page":"2912","DOI":"10.1182\/blood-2005-05-2004","volume":"106","author":"ML Sorror","year":"2005","unstructured":"Sorror ML et al (2005) Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT. Blood 106(8):2912\u20139. https:\/\/doi.org\/10.1182\/blood-2005-05-2004","journal-title":"Blood"},{"issue":"4","key":"6964_CR22","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1097\/00007890-197410000-00001","volume":"18","author":"H Glucksberg","year":"1974","unstructured":"Glucksberg H et al (1974) Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 18(4):295\u2013304. https:\/\/doi.org\/10.1097\/00007890-197410000-00001","journal-title":"Transplantation"},{"issue":"12","key":"6964_CR23","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.bbmt.2005.09.004","volume":"11","author":"AH Filipovich","year":"2005","unstructured":"Filipovich AH et al (2005) National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. diagnosis and staging working group report. Biol Blood Marrow Transplant 11(12):945\u201356. https:\/\/doi.org\/10.1016\/j.bbmt.2005.09.004","journal-title":"Biol Blood Marrow Transplant"},{"issue":"20","key":"6964_CR24","doi-asserted-by":"publisher","first-page":"5274","DOI":"10.1182\/bloodadvances.2024015626","volume":"9","author":"S DeWolf","year":"2025","unstructured":"DeWolf S et al (2025) Bone marrow and blood demonstrate distinct immune reconstitution patterns and correlations with relapse posttransplant. Blood Adv 9(20):5274\u20135282. https:\/\/doi.org\/10.1182\/bloodadvances.2024015626","journal-title":"Blood Adv"},{"issue":"3","key":"6964_CR25","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","volume":"48","author":"Y Kanda","year":"2013","unstructured":"Kanda Y (2013) Investigation of the freely available easy-to-use software \u201cEZR\u201d for medical statistics. Bone Marrow Transplant 48(3):452\u20138. https:\/\/doi.org\/10.1038\/bmt.2012.244","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"6964_CR26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0130026","volume":"10","author":"S Servais","year":"2015","unstructured":"Servais S et al (2015) Impact of pre-transplant anti-T cell globulin (ATG) on immune recovery after myeloablative allogeneic peripheral blood stem cell transplantation. PLoS One 10(6):e0130026. https:\/\/doi.org\/10.1371\/journal.pone.0130026","journal-title":"PLoS One"},{"issue":"3","key":"6964_CR27","doi-asserted-by":"publisher","first-page":"e620","DOI":"10.1093\/cid\/ciaa1871","volume":"73","author":"Y Akahoshi","year":"2021","unstructured":"Akahoshi Y et al (2021) Effect of cytomegalovirus reactivation with or without acute graft-versus-host disease on the risk of nonrelapse mortality,. Clin Infect Dis 73(3):e620\u2013e628. https:\/\/doi.org\/10.1093\/cid\/ciaa1871","journal-title":"Clin Infect Dis"},{"issue":"1","key":"6964_CR28","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1182\/bloodadvances.2021005509","volume":"6","author":"AT Turki","year":"2022","unstructured":"Turki AT et al (2022) Impact of CMV reactivation on relapse of acute myeloid leukemia after HCT is dependent on disease stage and ATG. Blood Adv 6(1):28\u201336. https:\/\/doi.org\/10.1182\/bloodadvances.2021005509","journal-title":"Blood Adv"},{"issue":"5","key":"6964_CR29","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1182\/blood-2010-08-304121","volume":"118","author":"AH Elmaagacli","year":"2011","unstructured":"Elmaagacli AH et al (2011) Early human cytomegalovirus replication after transplantation is associated with a decreased relapse risk: evidence for a putative virus-versus-leukemia effect in acute myeloid leukemia patients. Blood 118(5):1402\u201312. https:\/\/doi.org\/10.1182\/blood-2010-08-304121","journal-title":"Blood"},{"issue":"7","key":"6964_CR30","doi-asserted-by":"publisher","first-page":"825","DOI":"10.11406\/rinketsu.56.825","volume":"56","author":"K Takenaka","year":"2015","unstructured":"Takenaka K (2015) [Cytomegalovirus reactivation after allogeneic stem cell transplantation reduces the risk of relapse in patients with acute myeloid leukemia]. Rinsho Ketsueki 56(7):825\u201330. https:\/\/doi.org\/10.11406\/rinketsu.56.825","journal-title":"Rinsho Ketsueki"},{"issue":"7","key":"6964_CR31","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1182\/blood-2013-02-487074","volume":"122","author":"ML Green","year":"2013","unstructured":"Green ML et al (2013) CMV reactivation after allogeneic HCT and relapse risk: evidence for early protection in acute myeloid leukemia. Blood 122(7):1316\u201324. https:\/\/doi.org\/10.1182\/blood-2013-02-487074","journal-title":"Blood"},{"issue":"12","key":"6964_CR32","doi-asserted-by":"publisher","first-page":"2699","DOI":"10.1182\/bloodadvances.2022009376","volume":"7","author":"Y Akahoshi","year":"2023","unstructured":"Akahoshi Y et al (2023) CMV reactivation after allogeneic HCT is associated with a reduced risk of relapse in acute lymphoblastic leukemia. Blood Adv 7(12):2699\u20132708. https:\/\/doi.org\/10.1182\/bloodadvances.2022009376","journal-title":"Blood Adv"},{"issue":"3","key":"6964_CR33","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1111\/ajt.15642","volume":"20","author":"AT Turki","year":"2020","unstructured":"Turki AT et al (2020) Optimizing anti-T-lymphocyte globulin dosing to improve long-term outcome after unrelated hematopoietic cell transplantation for hematologic malignancies. Am J Transplant 20(3):677\u2013688. https:\/\/doi.org\/10.1111\/ajt.15642","journal-title":"Am J Transplant"},{"issue":"3","key":"6964_CR34","doi-asserted-by":"publisher","first-page":"622","DOI":"10.3324\/haematol.2018.199802","volume":"104","author":"CS Link-Rachner","year":"2019","unstructured":"Link-Rachner CS et al (2019) T-cell receptor-\u03b1 repertoire of CD8\u2009+\u2009T cells following allogeneic stem cell transplantation using next-generation sequencing. Haematologica 104(3):622\u2013631. https:\/\/doi.org\/10.3324\/haematol.2018.199802","journal-title":"Haematologica"},{"issue":"9","key":"6964_CR35","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1016\/j.bbmt.2020.04.026","volume":"26","author":"M Leick","year":"2020","unstructured":"Leick M et al (2020) T cell clonal dynamics determined by high-resolution TCR-\u03b2 sequencing in recipients after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 26(9):1567\u20131574. https:\/\/doi.org\/10.1016\/j.bbmt.2020.04.026","journal-title":"Biol Blood Marrow Transplant"},{"key":"6964_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1148841","volume":"14","author":"CD Lauruschkat","year":"2023","unstructured":"Lauruschkat CD et al (2023) CD4\u2009+\u2009T cells are the major predictor of HCMV control in allogeneic stem cell transplant recipients on letermovir prophylaxis,. Front Immunol 14:1148841. https:\/\/doi.org\/10.3389\/fimmu.2023.1148841","journal-title":"Front Immunol"},{"issue":"23","key":"6964_CR37","doi-asserted-by":"publisher","first-page":"2500","DOI":"10.1182\/blood.2022016926","volume":"140","author":"N Vallet","year":"2022","unstructured":"Vallet N et al (2022) Azithromycin promotes relapse by disrupting immune and metabolic networks after allogeneic stem cell transplantation. Blood 140(23):2500\u20132513. https:\/\/doi.org\/10.1182\/blood.2022016926","journal-title":"Blood"},{"issue":"1","key":"6964_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-022-01287-3","volume":"15","author":"C Zhao","year":"2022","unstructured":"Zhao C et al (2022) Post-transplant cyclophosphamide alters immune signatures and leads to impaired T cell reconstitution in allogeneic hematopoietic stem cell transplant. J Hematol Oncol 15(1):64. https:\/\/doi.org\/10.1186\/s13045-022-01287-3","journal-title":"J Hematol Oncol"},{"issue":"7","key":"6964_CR39","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1038\/sj.leu.2404683","volume":"21","author":"M Mohty","year":"2007","unstructured":"Mohty M (2007) Mechanisms of action of antithymocyte globulin: T-cell depletion and beyond. Leukemia 21(7):1387\u201394. https:\/\/doi.org\/10.1038\/sj.leu.2404683","journal-title":"Leukemia"},{"issue":"6","key":"6964_CR40","doi-asserted-by":"publisher","first-page":"518.e1","DOI":"10.1016\/j.jtct.2021.03.003","volume":"27","author":"A Sperotto","year":"2021","unstructured":"Sperotto A et al (2021) Cytomegalovirus prophylaxis versus pre-emptive strategy: different CD4\u2009+\u2009and CD8\u2009+\u2009T cell reconstitution after allogeneic hematopoietic stem cell transplantation. Transplant Cell Ther 27(6):518.e1\u2013518.e4. https:\/\/doi.org\/10.1016\/j.jtct.2021.03.003","journal-title":"Transplant Cell Ther"},{"issue":"10","key":"6964_CR41","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1038\/bmt.2010.306","volume":"46","author":"L B\u00fchlmann","year":"2011","unstructured":"B\u00fchlmann L et al (2011) Lymphocyte subset recovery and outcome after T-cell replete allogeneic hematopoietic SCT. Bone Marrow Transplant 46(10):1357\u201362. https:\/\/doi.org\/10.1038\/bmt.2010.306","journal-title":"Bone Marrow Transplant"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-026-06964-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-026-06964-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-026-06964-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T05:59:51Z","timestamp":1776405591000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-026-06964-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,2]]},"references-count":41,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["6964"],"URL":"https:\/\/doi.org\/10.1007\/s00277-026-06964-8","relation":{},"ISSN":["1432-0584"],"issn-type":[{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,2]]},"assertion":[{"value":"5 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Anjo Kosei Hospital\u2019s institutional review board (Anjo, Japan) reviewed and authorized the study protocol. The Helsinki Declaration was followed. Informed consent was obtained from all individual participants included this study in the written form.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"224"}}